Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H33N9O15P2 |
Molecular Weight | 785.5497 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N4C=NC5=C4N=CN=C5N)C6=NC(=O)NC(=O)C6=N2
InChI
InChIKey=VWWQXMAJTJZDQX-UYBVJOGSSA-N
InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1
Molecular Formula | C27H33N9O15P2 |
Molecular Weight | 785.5497 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including:
http://www.wikidoc.org/index.php/FAD
http://www.drugbank.ca/drugs/DB03147
Curator's Comment: description was created based on several sources, including:
http://www.wikidoc.org/index.php/FAD
http://www.drugbank.ca/drugs/DB03147
Flavin adenine dinucleotide is a coenzyme form of vitamin B2. Many oxidoreductases, called flavoenzymes or flavoproteins, require FAD as a prosthetic group, which functions in electron transfers. It is usually used for the prevention and treatment of various diseases that are caused by Vitamin B2 deficiency or metabolic disorder including stomatitis, eczema, etc. No adverse reactions were reported.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Flavitan Approved UseIt is usually used for the prevention and treatment of various diseases that are caused by Vitamin B2 deficiency Launch Date-9.9273597E10 |
|||
Palliative | Flavitan Approved UseIt is an effective in conjunctivitis treatment. Launch Date-9.9273597E10 |
|||
Palliative | Flavitan Approved UseIt is usually used for the prevention and treatment of metabolic disorder including stomatitis. Launch Date-9.9273597E10 |
PubMed
Title | Date | PubMed |
---|---|---|
Mechanism of chlorpromazine-induced arrhythmia -- arrhythmia and mitochondrial dysfunction. | 1981 Jul |
|
ACP1GUA-1--a low-activity variant of human erythrocyte acid phosphatase: association with increased glutathione reductase activity. | 1982 May |
|
Quantification of riboflavin, riboflavin 5'-phosphate and flavin adenine dinucleotide in plasma and urine by high-performance liquid chromatography. | 1987 Dec 25 |
|
Riboflavin metabolism in the hypothyroid newborn. | 1988 Mar |
|
Flavin adenine dinucleotide levels in erythrocytes of very low birthweight infants under vitamin supplementation. | 1993 |
|
Determination of riboflavin and flavocoenzymes in human blood plasma by high-performance liquid chromatography. | 1995 |
|
Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. | 2001 Mar |
|
Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient. | 2006 Mar |
|
Identification and functional characterization of rat riboflavin transporter 2. | 2009 Apr |
Patents
Sample Use Guides
Oral: Take 5 to 45 mg of flavin adenine dinucleotide per day in 1 to 3 divided doses.
Injection: 40 mg one or two times per day
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5822598
The addition of 1uM of FAD was found to exert a consistent activation effect on Glutathione reductase activity.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:35:47 UTC 2023
by
admin
on
Fri Dec 15 17:35:47 UTC 2023
|
Record UNII |
ZC44YTI8KK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
53647-4
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
||
|
LOINC |
78991-7
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
||
|
LOINC |
78990-9
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
||
|
LOINC |
2281-4
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
||
|
NCI_THESAURUS |
C26017
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
146-14-5
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
ZC44YTI8KK
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
DB03147
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
16238
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
m5392
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | Merck Index | ||
|
205-663-1
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
ZC44YTI8KK
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
DTXSID4048307
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
SUB13892MIG
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
FLAVIN ADENINE DINUCLEOTIDE
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
100000078499
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
643975
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
C80888
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
1314412
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
CHEMBL1232653
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY | |||
|
112207
Created by
admin on Fri Dec 15 17:35:47 UTC 2023 , Edited by admin on Fri Dec 15 17:35:47 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |